Placenta
Volume 28, Issue 5 , Pages 566-570 , May 2007

Does Immune Stimulation or Antioxidant Therapy Reduce MNU-induced Placental Damage Via Activation of Jak-STAT and NFκB Signaling Pathways?

  • M.R. Prater

      Affiliations

    • The Edward Via Virginia College of Osteopathic Medicine, Department of Biomedical Sciences, 2265 Kraft Drive, Blacksburg, VA 24060, USA
    • Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Department of Biomedical Science and Pathobiology, Phase II Duck Pond Drive, Blacksburg, VA 24061, USA
    • Corresponding Author InformationCorresponding author. The Edward Via Virginia College of Osteopathic Medicine, Department of Biomedical Sciences, 2265 Kraft Drive, Blacksburg, VA 24060, USA. Tel.: +1 540 231 3996 (office); fax: +1 540 231 5252.
    • ,
  • C.L. Laudermilch

      Affiliations

    • Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Department of Biomedical Science and Pathobiology, Phase II Duck Pond Drive, Blacksburg, VA 24061, USA
    • ,
  • S.D. Holladay

      Affiliations

    • Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Department of Biomedical Science and Pathobiology, Phase II Duck Pond Drive, Blacksburg, VA 24061, USA

,Accepted 10 May 2006.

References 

  1. Alexandrov VA. Some results and prospects of transplacental carcinogenesis studies. Neoplasma. 1976;23:285–299
  2. Prater MR, Zimmerman KL, Ward DL, Holladay SD. Reduced birth defects caused by maternal immune stimulation in methylnitrosourea-exposed mice: association with placental improvement. Birth Defects Res Part A Clin Mol Teratol. 2004;70:862–869
  3. Drablos F, Feyzi E, Aas PA, Vaagbo CB, Kavli B, Bratlie MS, et al. Alkylation damage in DNA and RNA-repair mechanisms and medical significance. DNA Repair (Amst). 2004;3:1389–1407
  4. Prater MR, Zimmerman KL, Pinn LC, Keay JM, Laudermilch CL, Holladay SD. Role of maternal dietary antioxidant supplementation in murine placental and fetal limb development. Placenta. 2006;27:502–509
  5. Laudermilch CL, Holladay SD, Sponenberg DP, Saunders GK, Ward DL, Prater MR. Placental improvement and reduced distal limb defects by maternal interferon-gamma injection in methylnitrosourea-exposed mice. Birth Defects Res Part A Clin Mol Teratol. 2005;73:597–604
  6. Holladay SD, Sharova LV, Punareewattana K, Hrubec TC, Gogal RM, Prater MR, et al. Maternal immune stimulation in mice decreases fetal malformations caused by teratogens. Int Immunopharmacol. 2002;2:325–332
  7. Cramer M, Nagy I, Murphy BJ, Gassmann M, Hottiger MO, Georgiev O, et al. NF-kappaB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells. Biol Chem. 2005;386:865–872
  8. Bjorbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res. 2004;59:305–331
  9. Poehlmann TG, Busch S, Mussil B, Winzer H, Weinert J, Mebes I, et al. The possible role of the Jak/STAT pathway in lymphocytes at the fetomaternal interface. Chem Immunol Allergy. 2005;89:26–35
  10. Hrubec TC, Prater MR, Toops KA, Holladay SD. Reduction in diabetes-induced craniofacial defects by maternal immune stimulation. Birth Defects Res Part B Dev Reprod Toxicol. 2006;77:1–9
  11. Sharova L, Sura P, Smith BJ, Gogal RM, Sharov AA, Ward DL, et al. Nonspecific stimulation of the maternal immune system. II. Effects on gene expression in the fetus. Teratology. 2000;62:420–428
  12. Smith SB, Cooke CB, Yielding KL. Effects of the antioxidant butylated hydroxytoluene (BHT) on retinal degeneration induced transplacentally by a single low dosage of N-methyl-N-nitrosourea (MNU). Teratog Carcinog Mutagen. 1988;8:175–189
  13. Schindler C, Darnell JE. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem. 1995;64:621–651
  14. Reddy EP, Korapati A, Chaturvedi P, Rane S. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene. 2000;19:2532–2547
  15. Fitzgerald JS, Busch S, Wengenmayer T, Foerster K, de la Motte T, Poehlmann TG, et al. Signal transduction in trophoblast invasion. Chem Immunol Allergy. 2005;88:181–199
  16. Bright JJ, Sriram S. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J Immunol. 1998;161:1772–1777
  17. Ward AC, Touw I, Yoshimura A. The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood. 2000;95:19–29
  18. Decker T, Stockinger S, Karaghiosoff M, Muller M, Kovarik P. IFNs and STATs in innate immunity to microorganisms. J Clin Invest. 2002;109:1271–1277
  19. Matthiesen L, Berg G, Ernerudh J, Ekerfelt C, Jonsson Y, Sharma S. Immunology of preeclampsia. Chem Immunol Allergy. 2005;89:49–61
  20. Denison FC, Kelly RW, Calder AA, Riley SC. Cytokine secretion by human fetal membranes, decidua and placenta at term. Hum Reprod. 1998;13:3560–3565
  21. Hennessy A, Pilmore HL, Simmons LA, Painter DM. A deficiency of placental IL-10 in preeclampsia. J Immunol. 1999;163:3491–3495
  22. Wilczynski JR, Tchorzewski H, Banasik M, Glowacka E, Wieczorek A, Lewkowicz P, et al. Lymphocyte subset distribution and cytokine secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2003;109:8–15
  23. Jonsson Y, Matthiesen L, Berg G, Ernerudh J, Nieminen K, Ekerfelt C. Indications of an altered immune balance in preeclampsia: a decrease in in vitro secretion of IL-5 and IL-10 from blood mononuclear cells and in blood basophil counts compared with normal pregnancy. J Reprod Immunol. 2005;66:69–84
  24. Makris A, Xu B,Yu B, Thornton C, Hennessy A. Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta. 2005;26:828–834
  25. Hassink SG, de Lancey E, Sheslow DV, Smith-Kirwin SM, O'Connor DM, Considine RV, et al. Placental leptin: an important new growth factor in intrauterine and neonatal development?. Pediatrics. 1997;100:[E1]
  26. Bajoria R, Sooranna SR, Ward BS, Chatterjee R. Prospective function of placental leptin at maternal–fetal interface. Placenta. 2002;23:103–115
  27. Ashworth CJ, Hoggard N, Thomas L, Mercer JG, Wallace JM, Lea RG. Placental leptin. Rev Reprod. 2000;5:18–24
  28. Sagawa N, Yura S, Itoh H, Mise H, Kakui K, Korita D, et al. Role of leptin in pregnancy – a review. Placenta. 2002;23(Suppl. A):S80–S86
  29. Nilsson C, Swolin-Eide D, Ohlsson C, Eriksson E, Ho HP, Bjorntorp P, et al. Reductions in adipose tissue and skeletal growth in rat adult offspring after prenatal leptin exposure. J Endocrinol. 2003;176:13–21
  30. Javaid MK, Godfrey KM, Taylor P, Robinson SM, Crozier SR, Dennison EM, et al. Umbilical cord leptin predicts neonatal bone mass. Calcif Tissue Int. 2005;76:341–347
  31. Lappas M, Permezel M, Rice GE. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2. Endocrinology. 2005;146:3334–3342
  32. Meissner U, Spranger R, Lehner M, Allabauer I, Rascher W, Dotsch J. Hypoxia-induced leptin production in human trophoblasts does not protect from apoptosis. Eur J Endocrinol. 2005;153:455–461
  33. Meller M, Qiu C, Vadachkoria S, Abetew DF, Luthy DA, Williams MA. Changes in placental adipocytokine gene expression associated with gestational diabetes mellitus A. Physiol Res. 2005;[epub ahead of print]
  34. Rahmouni K, Haynes WG. Endothelial effects of leptin: implications in health and diseases. Curr Diab Rep. 2005;5:260–266
  35. Singh HJ, Abu Bakar A, Che Romli A, Nila A. Raised leptin concentrations in feto-placental tissues from women with preeclampsia. Hypertens Pregnancy. 2005;24:191–199
  36. Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem J. 2006;393:7–20
  37. Hayashi M, Hamada Y, Ohkura T. Elevation of granulocyte–macrophage colony-stimulating factor in the placenta and blood in preeclampsia. Am J Obstet Gynecol. 2004;190:456–461
  38. Dong M, He J, Wang Z, Xie X, Wang H. Placental imbalance of Th1- and Th2-type cytokines in preeclampsia. Acta Obstet Gynecol Scand. 2005;84:788–793
  39. Frolich M, Datta S, Corn SB. Thrombopoietin in normal pregnancy and preeclampsia. Am J Obstet Gynecol. 1998;179:100–104
  40. Karalis I, Nadar SK, Al Yemeni E, Blann AD, Lip GY. Platelet activation in pregnancy-induced hypertension. Thromb Res. 2005;116:377–383
  41. Walch L, Massade L, Dufilho M, Brunet A, Rendu F. Pro-atherogenic effect of interleukin-4 in endothelial cells: modulation of oxidative stress, nitric oxide and monocyte chemoattractant protein-1 expression. Atherosclerosis. 2005;[epub ahead of print]
  42. Tamasi L, Bohacs A, Pallinger E, Falus A, Rigo J, Muller V, et al. Increased interferon-gamma- and interleukin-4-synthesizing subsets of circulating T lymphocytes in pregnant asthmatics. Clin Exp Allergy. 2005;35:1197–1203
  43. Guo A, Zhang M, Tang H, Cao X. Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines. Blood. 2005;106:2033–2041
  44. Poppema S. Immunobiology and pathophysiology of hodgkin lymphomas. Hematology (Am Soc Hematol Educ Program). 2005;231–238
  45. Aban M, Cinel L, Arslan M, Dilek U, Kaplanoglu M, Arpaci R, et al. Expression of nuclear factor-kappa B and placental apoptosis in pregnancies complicated with intrauterine growth restriction and preeclampsia: an immunohistochemical study. Tohoku J Exp Med. 2004;204:195–202
  46. Altinoz MA, Korkmaz R. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. Neoplasma. 2004;51:239–247
  47. Zhang WJ, Frei B. Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J. 2001;15:2423–2432
  48. Katabuchi H, Yih S, Ohba T, Matsui K, Takahashi K, Takeya M, et al. Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells. Med Electron Microsc. 2003;36:253–262
  49. He Y, Smith SK, Day KA, Clark DE, Licence DR, Charnock-Jones DS. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol. 1999;13:537–545
  50. Knackstedt MK, Zenclussen AC, Hertwig K, Hagen E, Dudenhausen JW, Clark DA, et al. Th1 cytokines and the prothrombinase fgl2 in stress-triggered and inflammatory abortion. Am J Reprod Immunol. 2003;49:210–220
  51. McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ, McClure N. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol. 2004;191:1240–1246
  52. Glabowski W, Kurzawa R, Wiszniewska B, Baczkowski T, Marchlewicz M, Brelik P. Growth factors effects on preimplantation development of mouse embryos exposed to tumor necrosis factor alpha. Reprod Biol. 2005;5:83–99
  53. Takacs P, Kauma SW, Sholley MM, Walsh SW, Dinsmoor MJ, Green K. Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells. FASEB J. 2001;15:279–281
  54. Peng Y, Kwok KH, Yang PH, Ng SS, Liu J, Wong OG, et al. Ascorbic acid inhibits ROS production, NF-kappa B activation and prevents ethanol-induced growth retardation and microencephaly. Neuropharmacology. 2005;48:426–434
  55. Mackova M, Kilani RT, Davidge ST, Guilbert LJ. The effect of oxygen tension on intracellular survival signaling in primary villous trophoblasts. Placenta. 2003;24:627–637

PII: S0143-4004(06)00125-1

doi: 10.1016/j.placenta.2006.05.002

Placenta
Volume 28, Issue 5 , Pages 566-570 , May 2007

Article Tools

* Image Usage & Resolution